Fosun Teams Up With UK Healthcare Firm Arix Bioscience To Develop Clinical Therapies In China

Login to View

Fosun International Ltd. (00656:HK) and London-based healthcare and life science company Arix Bioscience plc (LSE:ARIX) have jointly announced a strategic agreement to develop and commercialize new clinical therapies for patients with a focus on the Chinese markets.

Continue reading with a China Money Network subscription

Join Now

Already have an account or paid subscription? Log in